Digital
20th - 23rd October 2020

MarketsandMarkets Biomarker and Companion Diagnostics Virtual Conference (EST TIME ZONE)

Leveraging next gen technologies beyond conventional biomarker drug discovery

The emergence of the need for safety and efficacy of a drug subjected to individual patients has made companion diagnostics one of the most sought after topics in the field of In-Vitro Diagnostics. The surge of investment in companion diagnostics has brought forward issues regarding regulations and their intricacies and boosted new trends in immuno-oncology, immuno-therapies, data interpretation and unconventional design of clinical trials.

The Biomarker and Companion Diagnostics Virtual Conference scheduled to be held on 20-23 October 2020 would address the gaps between early-stage biomarker development and the commercialization stage of biomarkers.

This conference would also highlight case studies on leveraging emerging technologies in Digital Biomarkers, Precision Medicine and Big Data. Regarding the commercialization of biomarkers, leading industry and academic experts would share their case studies focusing on advancements in the companion diagnostics area. The keynote presentations would also help the attendees understand the issues related to the clinical translation of biomarkers.

WHAT TO EXPECT

Key Highlights

  • Commercialization of CDx
  • Proteomics and Genomics based Biomarkers
  • Biomarker Drug Discovery and Assay Development
  • Multiplex Companion Diagnostics and Regulatory Guidelines
  • Design of clinical trials in CDx
  • Digital Biomarkers, Predictive Biomarkers, Precision Medicine and Big Data
  • Clinical Applications of Biomarkers in Immuno-Oncology, Neurology and Inflammatory Diseases

Who Should Attend?

Researchers, scientists, clinicians, academicians and professionals from Pharmaceutical companies, Bio-pharma companies & Universities and Research institutes working in:

  • Biomarker discovery/development
  • Translational research
  • Clinical Biomarker
  • Biomarkers in IO and Neurological disorders
  • Imaging Biomarkers
  • Pathology
  • Companion Diagnostics
  • Biomarker Imaging
  • Proteomics Biomarkers
  • Experimental Medicine
  • Data Science
  • Biomarkers in Clinical Discovery
  • Immuno-oncology/Neuroscience Drug Discovery
  • Diagnostic Biomarkers development
  • Personalized Medicine
  • Immunology Biomarkers

CONFERENCE AGENDA
INNOVATIONS IN BIOMARKER RESEARCH: DIGITAL BIOMARKERS, PRECISION MEDICINE AND BIG DATA
IDENTIFICATION OF RIGHT BIOMARKERS & DESIGN OF CLINICAL TRIALS IN CDX
CONFERENCE SPEAKERS
Speakers
Roy Baynes
Roy Baynes
Senior Vice President and Head Global Clinical Development, Chief Medical Officer, Merck Research Laboratories
John Rossi,
John Rossi,
Vice President, Head, Translational Medicine, , Syncopation Lifesciences
Mike Baratta
Mike Baratta
Scientific Director, Translational Biomarker Research , Takeda
Pallavi Sachdev
Pallavi Sachdev
Senior Director, Clinical Pharmacology and Translational Medicine, Eisai
Adil Daud
Adil Daud
Clinical Professor , UCSF
Kevin Wang
Kevin Wang
Director, Program for Neuroproteomics and Biomarkers Research, University of Florida
Ian Pike
Ian Pike
Chief Scientific Officer, Proteome Sciences PLC
George Pell
George Pell
CEO and Founder, Thirty-Six
SPONSORS
Platinium
example-image

QIAGEN

Gold
example-image

Burning Rock

example-image

Owlstone Medical

example-image

Agilent

Silver
example-image

Larvol

example-image

Abcam

Sponsors & Exhibitors
example-image

Proteome Sciences

Speaking Partner
example-image

NeoGenomics

example-image

Eutropics

example-image

RareCyte

example-image

Cureline

Meeting Partner
example-image

International Drug Development Institute

example-image

Biodesix

PAST EVENT GALLERY